Democrats ask NIH for Xtandi march-in hearing

A group of 12 U.S. House and Senate Democrats sent a Xtandi enzalutamide from Astellas Pharma Inc. (Tokyo:4503).

In January, two patient advocacy groups asked

Read the full 259 word article

User Sign In